José Luis Calleja

21PUBLICATIONS
156CO-AUTHORS
Medical biochemistry - lipidsDisease surveillanceMetabolic medicinePacific Peoples theory of change models for healthClinical nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Mar 30, 2026
Two-step clinical care pathway to predict MASLD-related advanced fibrosis and long-term outcomes in type 2 diabetes.

Yuping Chen, Bingtian Dong, Xinrui Jin

|Jun 20, 2025
Non-invasive risk-based surveillance of hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease.

Jimmy Che-To Lai, Boyu Yang, Hye Won Lee

|Aug 05, 2024
One-step non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis and fibrosis in high-risk population.

Paula Iruzubieta, Rebeca Mayo, Itziar Mincholé

|Aug 01, 2024
Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease.

Xiao-Dong Zhou, Seung Up Kim, Terry Cheuk-Fung Yip

|Jun 19, 2024
Fibroblast growth factor 21 is a hepatokine involved in MASLD progression.

Rocío Gallego-Durán, Javier Ampuero, Douglas Maya-Miles

|May 02, 2024
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir.

Juan Carlos Ruiz-Cobo, Jordi Llaneras, Xavier Forns

Pageof 4

Frequent Collaborators

5 joint publications

Manuel Romero-Gómez

4 joint publications

Javier Crespo

3 joint publications

Elba Llop

3 joint publications

Elisabetta Bugianesi